Veracyte (VCYT) Tops Q3 EPS by 19c, provides guidance

Veracyte (NASDAQ: VCYT) reported Q3 EPS of $0.51, $0.19 better than the analyst estimate of $0.32. Revenue for the quarter came in at $131.9 million versus the consensus estimate of $124.78 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $506-510 million, versus the consensus of $500.2 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Iran, Oman Foreign Mins. Discuss Shipping In Strait Of Hormuz
• Donaldson (DCI) call put ratio 1 call to 2.6 puts into quarter results
• Anthropic To Tell Investors It Sees Over $30T In Rev - WSJ